(Q34759870)

4 August 2017

title

Diagnostic importance of 9p21 homozygous deletion in malignant mesotheliomas (English)

1 reference

4 August 2017

1 reference

Simion Chiosea

1

1 reference

4 August 2017

Alyssa Krasinskas

2

1 reference

4 August 2017

Philip T Cagle

3

1 reference

4 August 2017

Kisha A Mitchell

4

1 reference

4 August 2017

Dani S Zander

5

1 reference

4 August 2017

Sanja Dacic

6

1 reference

4 August 2017

publication date

7 March 2008

1 reference

4 August 2017

1 reference

4 August 2017

volume

21

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

742-747

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.2008.45

4 August 2017

exact match

0 references

cites work

The separation of benign and malignant mesothelial proliferations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

Malignant mesothelioma of the peritoneum presenting as an inflammatory lesion: a report of four cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

Cytogenetic and molecular genetic changes in malignant mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

Comparison of monoclonal versus polyclonal calretinin antibodies for immunohistochemical diagnosis of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

Reactive mesothelial hyperplasia vs mesothelioma, including mesothelioma in situ: a brief review

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

The use of epithelial membrane antigen and silver-stained nucleolar organizer regions testing in the differential diagnosis of mesothelioma from benign reactive mesothelioses

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

P16 and Ki67 immunostaining is a useful adjunct in the assessment of biopsies for HPV-associated anal intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

Alterations of the p16(INK4) locus in human malignant mesothelial tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

P16 loss and mitotic activity predict poor survival in patients with peritoneal malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.2008.45

7 January 2021

10.1038/MODPATHOL.2008.45

Identifiers

DOI

1 reference

Dimensions Publication ID

4 August 2017

1038938629

0 references

1 reference